10x Genomics (NASDAQ:TXG) made its public debut Thursday morning, opening at $54 after being priced at $39 per share.
The firm plans to trade on the Nasdaq under ticker symbol "TXG.”
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
See Aslo: 10X Genomics IPO: What You Need To Know
10x Genomics markets the Chromium single-cell analysis system and assay kits, announced its plans for an IPO last month. Initially, its filing said it was looking to raise up to $100 million.
JPMorgan, Goldman Sachs and Bank of America Merrill Lynch are acting as lead joint book-running managers for the offering. Cowen is acting as lead manager for the offering.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.